Published in Nat Immunol on February 10, 2008
T cell activation. Annu Rev Immunol (2009) 7.40
Oncogenic activation of NF-kappaB. Cold Spring Harb Perspect Biol (2010) 3.30
Dectin-1 is an extracellular pathogen sensor for the induction and processing of IL-1β via a noncanonical caspase-8 inflammasome. Nat Immunol (2012) 2.94
Programmed cell death in the plant immune system. Cell Death Differ (2011) 2.42
Targeting pathological B cell receptor signalling in lymphoid malignancies. Nat Rev Drug Discov (2013) 2.31
MALT1 small molecule inhibitors specifically suppress ABC-DLBCL in vitro and in vivo. Cancer Cell (2012) 2.18
Signaling to NF-kappaB: regulation by ubiquitination. Cold Spring Harb Perspect Biol (2010) 2.15
Inflammatory T cell responses rely on amino acid transporter ASCT2 facilitation of glutamine uptake and mTORC1 kinase activation. Immunity (2014) 2.14
Antigen receptor signaling to NF-kappaB via CARMA1, BCL10, and MALT1. Cold Spring Harb Perspect Biol (2010) 1.95
Essential role of MALT1 protease activity in activated B cell-like diffuse large B-cell lymphoma. Proc Natl Acad Sci U S A (2009) 1.90
Expanding role of ubiquitination in NF-κB signaling. Cell Res (2010) 1.89
Malignant pirates of the immune system. Nat Immunol (2011) 1.87
Inhibition of MALT1 protease activity is selectively toxic for activated B cell-like diffuse large B cell lymphoma cells. J Exp Med (2009) 1.80
Selective C-Rel activation via Malt1 controls anti-fungal T(H)-17 immunity by dectin-1 and dectin-2. PLoS Pathog (2011) 1.62
Pathogenetic importance and therapeutic implications of NF-κB in lymphoid malignancies. Immunol Rev (2012) 1.60
NF-κB signaling pathways regulated by CARMA family of scaffold proteins. Cell Res (2010) 1.58
T-cell receptor-induced JNK activation requires proteolytic inactivation of CYLD by MALT1. EMBO J (2011) 1.52
Malt1-dependent RelB cleavage promotes canonical NF-kappaB activation in lymphocytes and lymphoma cell lines. Proc Natl Acad Sci U S A (2011) 1.48
CARMA1- and MyD88-dependent activation of Jun/ATF-type AP-1 complexes is a hallmark of ABC diffuse large B-cell lymphomas. Blood (2016) 1.45
CARMA1-mediated NF-kappaB and JNK activation in lymphocytes. Immunol Rev (2009) 1.44
Critical role of PI3K signaling for NF-kappaB-dependent survival in a subset of activated B-cell-like diffuse large B-cell lymphoma cells. Proc Natl Acad Sci U S A (2010) 1.40
Structural architecture of the CARMA1/Bcl10/MALT1 signalosome: nucleation-induced filamentous assembly. Mol Cell (2013) 1.31
Cleavage of NIK by the API2-MALT1 fusion oncoprotein leads to noncanonical NF-kappaB activation. Science (2011) 1.30
Expression of MALT1 oncogene in hematopoietic stem/progenitor cells recapitulates the pathogenesis of human lymphoma in mice. Proc Natl Acad Sci U S A (2012) 1.19
Crystal structure of the mucosa-associated lymphoid tissue lymphoma translocation 1 (MALT1) paracaspase region. Proc Natl Acad Sci U S A (2011) 1.18
The paracaspase MALT1 controls caspase-8 activation during lymphocyte proliferation. Mol Cell (2008) 1.15
MALT1 protease: a new therapeutic target in B lymphoma and beyond? Clin Cancer Res (2011) 1.12
Processing of metacaspase into a cytoplasmic catalytic domain mediating cell death in Leishmania major. Mol Microbiol (2010) 1.11
The NF-κB regulator MALT1 determines the encephalitogenic potential of Th17 cells. J Clin Invest (2012) 1.10
From MALT lymphoma to the CBM signalosome: three decades of discovery. Cell Cycle (2011) 1.05
The CARD11-BCL10-MALT1 (CBM) signalosome complex: Stepping into the limelight of human primary immunodeficiency. J Allergy Clin Immunol (2014) 1.04
The protease activity of the paracaspase MALT1 is controlled by monoubiquitination. Nat Immunol (2013) 1.04
The CARMA3-Bcl10-MALT1 signalosome promotes angiotensin II-dependent vascular inflammation and atherogenesis. J Biol Chem (2010) 1.04
Protease activity of the API2-MALT1 fusion oncoprotein in MALT lymphoma development and treatment. Future Oncol (2011) 1.03
Thrombin-dependent NF-{kappa}B activation and monocyte/endothelial adhesion are mediated by the CARMA3·Bcl10·MALT1 signalosome. J Biol Chem (2010) 1.01
Regulation of NF-κB induction by TCR/CD28. Immunol Res (2011) 0.99
Regulation of NF-κB signaling by caspases and MALT1 paracaspase. Cell Res (2010) 0.98
Multiple protein domains mediate interaction between Bcl10 and MALT1. J Biol Chem (2008) 0.98
A new look at T cell receptor signaling to nuclear factor-κB. Trends Immunol (2013) 0.97
Coregulation and modulation of NFκB-related genes in celiac disease: uncovered aspects of gut mucosal inflammation. Hum Mol Genet (2013) 0.97
Malt1 protease inactivation efficiently dampens immune responses but causes spontaneous autoimmunity. EMBO J (2014) 0.96
Calcium-dependent activation and autolysis of Arabidopsis metacaspase 2d. J Biol Chem (2011) 0.96
Mechanism and specificity of the human paracaspase MALT1. Biochem J (2012) 0.96
Malt1 and cIAP2-Malt1 as effectors of NF-kappaB activation: kissing cousins or distant relatives? Cell Signal (2009) 0.96
Consequences of the recurrent MYD88(L265P) somatic mutation for B cell tolerance. J Exp Med (2014) 0.94
Quantitative phosphoproteomic analysis reveals a role for serine and threonine kinases in the cytoskeletal reorganization in early T cell receptor activation in human primary T cells. Mol Cell Proteomics (2012) 0.92
The E3 ubiquitin ligase mind bomb-2 (MIB2) protein controls B-cell CLL/lymphoma 10 (BCL10)-dependent NF-κB activation. J Biol Chem (2011) 0.92
Changes in the MALT1-A20-NF-κB expression pattern may be related to T cell dysfunction in AML. Cancer Cell Int (2013) 0.90
The paracaspase MALT1 cleaves HOIL1 reducing linear ubiquitination by LUBAC to dampen lymphocyte NF-κB signalling. Nat Commun (2015) 0.89
Molecular basis of lysophosphatidic acid-induced NF-κB activation. Cell Signal (2010) 0.89
PKCθ/β and CYLD are antagonistic partners in the NFκB and NFAT transactivation pathways in primary mouse CD3+ T lymphocytes. PLoS One (2013) 0.88
Pharmacological inhibition of MALT1 protease activity protects mice in a mouse model of multiple sclerosis. J Neuroinflammation (2014) 0.88
T cell receptor-dependent activation of mTOR signaling in T cells is mediated by Carma1 and MALT1, but not Bcl10. Sci Signal (2014) 0.88
Finally, MALT1 is a protease! Nat Immunol (2008) 0.87
MALT1 Protease Activity Is Required for Innate and Adaptive Immune Responses. PLoS One (2015) 0.84
MALT1 auto-proteolysis is essential for NF-κB-dependent gene transcription in activated lymphocytes. PLoS One (2014) 0.83
The paracaspase MALT1: biological function and potential for therapeutic inhibition. Cell Mol Life Sci (2015) 0.82
The role of CARMA1 in T cells. Crit Rev Immunol (2013) 0.81
Alternative splicing of MALT1 controls signalling and activation of CD4(+) T cells. Nat Commun (2016) 0.81
Monoubiquitination and activity of the paracaspase MALT1 requires glutamate 549 in the dimerization interface. PLoS One (2013) 0.80
Protein ubiquitination in lymphoid malignancies. Immunol Rev (2015) 0.80
Role and therapeutic potential of G-protein coupled receptors in breast cancer progression and metastases. Eur J Pharmacol (2015) 0.79
USP2a positively regulates TCR-induced NF-κB activation by bridging MALT1-TRAF6. Protein Cell (2012) 0.79
L-CBM signaling in lymphocyte development and function. J Blood Med (2010) 0.79
MALT1 is required for EGFR-induced NF-κB activation and contributes to EGFR-driven lung cancer progression. Oncogene (2015) 0.79
Lymphomagenic CARD11/BCL10/MALT1 signaling drives malignant B-cell proliferation via cooperative NF-κB and JNK activation. Proc Natl Acad Sci U S A (2015) 0.78
Probes to monitor activity of the paracaspase MALT1. Chem Biol (2014) 0.78
TCR signaling to NF-κB and mTORC1: Expanding roles of the CARMA1 complex. Mol Immunol (2015) 0.77
MALT1 is an intrinsic regulator of regulatory T cells. Cell Death Differ (2015) 0.77
Role of the CARMA1/BCL10/MALT1 complex in lymphoid malignancies. Curr Opin Hematol (2016) 0.77
Masking MALT1: the paracaspase's potential for cancer therapy. J Exp Med (2009) 0.77
The Paracaspase MALT1. Biochimie (2015) 0.76
Short Communication: Preferential Killing of HIV Latently Infected CD4(+) T Cells by MALT1 Inhibitor. AIDS Res Hum Retroviruses (2016) 0.76
Crystallization and preliminary X-ray crystallographic studies of the CARD domain of human CARMA1. Acta Crystallogr Sect F Struct Biol Cryst Commun (2013) 0.76
NKT sublineage specification and survival requires the ubiquitin-modifying enzyme TNFAIP3/A20. J Exp Med (2016) 0.76
Phosphatidylinositol 4-Phosphate 5-Kinases in the Regulation of T Cell Activation. Front Immunol (2016) 0.75
Functional characterization of a BCL10 isoform in the rainbow trout Oncorhynchus mykiss. FEBS Open Bio (2015) 0.75
A role for MALT1 activity in Kaposi's sarcoma-associated herpes virus latency and growth of primary effusion lymphoma. Leukemia (2016) 0.75
MALT1 Protease Activation Triggers Acute Disruption of Endothelial Barrier Integrity via CYLD Cleavage. Cell Rep (2016) 0.75
The CBM signalosome: potential therapeutic target for aggressive lymphoma? Cytokine Growth Factor Rev (2013) 0.75
Backbone Assignment of the MALT1 Paracaspase by Solution NMR. PLoS One (2016) 0.75
Two Antagonistic MALT1 Auto-Cleavage Mechanisms Reveal a Role for TRAF6 to Unleash MALT1 Activation. PLoS One (2017) 0.75
MALT1 protease: equilibrating immunity versus tolerance. EMBO J (2014) 0.75
BCL10GFP fusion protein as a substrate for analysis of determinants required for mucosa-associated lymphoid tissue 1 (MALT1)-mediated cleavage. J Biomed Sci (2012) 0.75
MALT1 promotes melanoma progression through JNK/c-Jun signaling. Oncogenesis (2017) 0.75
Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1 Positively Modulates Matrix Metalloproteinase-9 Production in Alveolar Macrophages upon Toll-Like Receptor 7 Signaling and Influenza Virus Infection. Front Immunol (2017) 0.75
Mucosa-associated lymphoid tissue lymphoma translocation 1 as a novel therapeutic target for rheumatoid arthritis. Sci Rep (2017) 0.75
Effector function of human tumor-specific CD8 T cells in melanoma lesions: a state of local functional tolerance. Cancer Res (2004) 3.59
Exhaustion of tumor-specific CD8⁺ T cells in metastases from melanoma patients. J Clin Invest (2011) 3.28
Immune activation and CD8+ T-cell differentiation towards senescence in HIV-1 infection. PLoS Biol (2004) 3.20
CARMA1 is a critical lipid raft-associated regulator of TCR-induced NF-kappa B activation. Nat Immunol (2002) 3.16
Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909. J Clin Invest (2005) 3.11
Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy. Blood (2002) 2.88
The long form of FLIP is an activator of caspase-8 at the Fas death-inducing signaling complex. J Biol Chem (2002) 2.75
Interactions of tumor necrosis factor (TNF) and TNF receptor family members in the mouse and human. J Biol Chem (2006) 2.75
Activation of the IL-1beta-processing inflammasome is involved in contact hypersensitivity. J Invest Dermatol (2007) 2.73
Four functionally distinct populations of human effector-memory CD8+ T lymphocytes. J Immunol (2007) 2.59
Association of mutations in the NALP3/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis. Arthritis Rheum (2002) 2.58
Requirement for CARMA1 in antigen receptor-induced NF-kappa B activation and lymphocyte proliferation. Curr Biol (2003) 2.51
Two adjacent trimeric Fas ligands are required for Fas signaling and formation of a death-inducing signaling complex. Mol Cell Biol (2003) 2.50
Comprehensive expression analyses of neural cell-type-specific miRNAs identify new determinants of the specification and maintenance of neuronal phenotypes. J Neurosci (2013) 2.08
Antigen receptor signaling to NF-kappaB via CARMA1, BCL10, and MALT1. Cold Spring Harb Perspect Biol (2010) 1.95
NALP inflammasomes: a central role in innate immunity. Semin Immunopathol (2007) 1.91
Essential role of MALT1 protease activity in activated B cell-like diffuse large B-cell lymphoma. Proc Natl Acad Sci U S A (2009) 1.90
Leishmania RNA virus controls the severity of mucocutaneous leishmaniasis. Science (2011) 1.88
Extended co-expression of inhibitory receptors by human CD8 T-cells depending on differentiation, antigen-specificity and anatomical localization. PLoS One (2012) 1.77
New generation vaccine induces effective melanoma-specific CD8+ T cells in the circulation but not in the tumor site. J Immunol (2006) 1.74
Diagnosis and management of nail pigmentations. J Am Acad Dermatol (2007) 1.73
Unmodified self antigen triggers human CD8 T cells with stronger tumor reactivity than altered antigen. Proc Natl Acad Sci U S A (2008) 1.59
Antigenicity and immunogenicity of Melan-A/MART-1 derived peptides as targets for tumor reactive CTL in human melanoma. Immunol Rev (2002) 1.58
IκB-ζ controls the constitutive NF-κB target gene network and survival of ABC DLBCL. Blood (2013) 1.55
Utility of a protein fraction with cathepsin L-Like activity purified from cysticercus fluid of Taenia solium in the diagnosis of human cysticercosis. Am J Trop Med Hyg (2009) 1.53
Ectodysplasin A1 promotes placodal cell fate during early morphogenesis of ectodermal appendages. Development (2004) 1.53
MicroRNA-155 is required for effector CD8+ T cell responses to virus infection and cancer. Immunity (2013) 1.51
Malt1-dependent RelB cleavage promotes canonical NF-kappaB activation in lymphocytes and lymphoma cell lines. Proc Natl Acad Sci U S A (2011) 1.48
Thymic selection generates a large T cell pool recognizing a self-peptide in humans. J Exp Med (2002) 1.44
Differential gene expression in periportal and perivenous mouse hepatocytes. FEBS J (2006) 1.41
Exclusively benign dermoscopic pattern in a patient with acral melanoma. Arch Dermatol (2007) 1.40
Evidence for a TCR affinity threshold delimiting maximal CD8 T cell function. J Immunol (2010) 1.33
Mycobacterium tuberculosis subverts innate immunity to evade specific effectors. J Immunol (2006) 1.28
Human effector CD8+ T lymphocytes express TLR3 as a functional coreceptor. J Immunol (2006) 1.28
Junctional adhesion molecule-2 (JAM-2) promotes lymphocyte transendothelial migration. Blood (2002) 1.27
MicroRNA-22 (miR-22) overexpression is neuroprotective via general anti-apoptotic effects and may also target specific Huntington's disease-related mechanisms. PLoS One (2013) 1.25
Enrichment of human CD4+ V(alpha)24/Vbeta11 invariant NKT cells in intrahepatic malignant tumors. J Immunol (2009) 1.25
Selecting highly affine and well-expressed TCRs for gene therapy of melanoma. Blood (2007) 1.25
T cell division and death are segregated by mutation of TCRbeta chain constant domains. Immunity (2004) 1.24
RIP4 (DIK/PKK), a novel member of the RIP kinase family, activates NF-kappa B and is processed during apoptosis. EMBO Rep (2002) 1.23
Leishmania major metacaspase can replace yeast metacaspase in programmed cell death and has arginine-specific cysteine peptidase activity. Int J Parasitol (2006) 1.23
Targeting essential pathways in trypanosomatids gives insights into protozoan mechanisms of cell death. Parasit Vectors (2010) 1.22
Significant correction of disease after postnatal administration of recombinant ectodysplasin A in canine X-linked ectodermal dysplasia. Am J Hum Genet (2007) 1.20
Apoptotic markers in protozoan parasites. Parasit Vectors (2010) 1.16
Interplay between T cell receptor binding kinetics and the level of cognate peptide presented by major histocompatibility complexes governs CD8+ T cell responsiveness. J Biol Chem (2012) 1.16
HTT-lowering reverses Huntington's disease immune dysfunction caused by NFκB pathway dysregulation. Brain (2014) 1.13
A novel approach to characterize clonality and differentiation of human melanoma-specific T cell responses: spontaneous priming and efficient boosting by vaccination. J Immunol (2006) 1.13
Caspase-8 and c-FLIPL associate in lipid rafts with NF-kappaB adaptors during T cell activation. J Biol Chem (2007) 1.12
Ex vivo detectable human CD8 T-cell responses to cancer-testis antigens. Cancer Res (2006) 1.11
Processing of metacaspase into a cytoplasmic catalytic domain mediating cell death in Leishmania major. Mol Microbiol (2010) 1.11
Fine structural variations of alphabetaTCRs selected by vaccination with natural versus altered self-antigen in melanoma patients. J Immunol (2009) 1.09
Danger signaling through the inflammasome acts as a master switch between tolerance and sensitization. J Immunol (2008) 1.08
Leishmania RNA virus: when the host pays the toll. Front Cell Infect Microbiol (2012) 1.08
Dramatic response of vemurafenib-induced cutaneous lesions upon switch to dual BRAF/MEK inhibition in a metastatic melanoma patient. Melanoma Res (2014) 1.08
Phosphorylation of CARMA1: the link(er) to NF-kappaB activation. Immunity (2005) 1.07
Mechanism of extracellular signal-regulated kinase activation by the CB(1) cannabinoid receptor. Mol Pharmacol (2002) 1.05
Viral inhibitor of apoptosis vFLIP/K13 protects endothelial cells against superoxide-induced cell death. J Virol (2008) 1.05
The protease activity of the paracaspase MALT1 is controlled by monoubiquitination. Nat Immunol (2013) 1.04
Identification of swiprosin 1 in human lymphocytes. Proteomics (2004) 1.04
A novel negative regulatory function of the phosphoprotein associated with glycosphingolipid-enriched microdomains: blocking Ras activation. Blood (2007) 1.02
Phosphorylation of CARMA1 by HPK1 is critical for NF-kappaB activation in T cells. Proc Natl Acad Sci U S A (2009) 1.02
Clonotype selection and composition of human CD8 T cells specific for persistent herpes viruses varies with differentiation but is stable over time. J Immunol (2009) 1.01
Mechanisms that limit the in vitro proliferative potential of human CD8+ T lymphocytes. J Immunol (2005) 1.01
Genomic organization and gene expression in a chromosomal region of Leishmania major. Mol Biochem Parasitol (2004) 1.00
Distinct mechanisms control human naive and antigen-experienced CD8+ T lymphocyte proliferation. J Immunol (2006) 1.00
SHP-1 phosphatase activity counteracts increased T cell receptor affinity. J Clin Invest (2013) 1.00
Vaccination-induced functional competence of circulating human tumor-specific CD8 T-cells. Int J Cancer (2011) 0.99
Bcl10 controls TCR- and FcgammaR-induced actin polymerization. J Immunol (2007) 0.98
Dominant human CD8 T cell clonotypes persist simultaneously as memory and effector cells in memory phase. J Immunol (2009) 0.98
Expression of cysteine proteinase type I and II of Leishmania infantum and their recognition by sera during canine and human visceral leishmaniasis. Exp Parasitol (2003) 0.97
Role of Toll-like receptor 9 signaling in experimental Leishmania braziliensis infection. Infect Immun (2013) 0.97
In Vivo Persistence of Codominant Human CD8+ T Cell Clonotypes Is Not Limited by Replicative Senescence or Functional Alteration. J Immunol (2007) 0.97
Type I interferon drives dendritic cell apoptosis via multiple BH3-only proteins following activation by PolyIC in vivo. PLoS One (2011) 0.97
Neonatal treatment with recombinant ectodysplasin prevents respiratory disease in dogs with X-linked ectodermal dysplasia. Am J Med Genet A (2009) 0.96
Assessing ageing of individual T lymphocytes: mission impossible? Mech Ageing Dev (2007) 0.95
Plasmodium falciparum metacaspase PfMCA-1 triggers a z-VAD-fmk inhibitable protease to promote cell death. PLoS One (2011) 0.95
Endocannabinoids: a new family of lipid mediators involved in the regulation of neural cell development. Curr Pharm Des (2006) 0.95
Resistance to oxidative stress is associated with metastasis in mucocutaneous leishmaniasis. J Infect Dis (2006) 0.95
Distinct sets of alphabeta TCRs confer similar recognition of tumor antigen NY-ESO-1157-165 by interacting with its central Met/Trp residues. Proc Natl Acad Sci U S A (2008) 0.94
Detection of Leishmania RNA virus in Leishmania parasites. PLoS Negl Trop Dis (2013) 0.93
Sporozoite-mediated hepatocyte wounding limits Plasmodium parasite development via MyD88-mediated NF-kappa B activation and inducible NO synthase expression. J Immunol (2008) 0.93
Tumor antigen-specific FOXP3+ CD4 T cells identified in human metastatic melanoma: peptide vaccination results in selective expansion of Th1-like counterparts. Cancer Res (2009) 0.93
Biological activity of ectodysplasin A is conditioned by its collagen and heparan sulfate proteoglycan-binding domains. J Biol Chem (2009) 0.92
Muco-cutaneous leishmaniasis in the New World: the ultimate subversion. Virulence (2011) 0.92
Human melanoma-specific CD8(+) T-cells from metastases are capable of antigen-specific degranulation and cytolysis directly ex vivo. Oncoimmunology (2012) 0.92
Sensitive gene expression profiling of human T cell subsets reveals parallel post-thymic differentiation for CD4+ and CD8+ lineages. J Immunol (2007) 0.92
Functional interaction of Parkinson's disease-associated LRRK2 with members of the dynamin GTPase superfamily. Hum Mol Genet (2013) 0.92
Comparative protein profiling identifies elongation factor-1beta and tryparedoxin peroxidase as factors associated with metastasis in Leishmania guyanensis. Mol Biochem Parasitol (2005) 0.91